These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38589784)

  • 1. Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review.
    Huang W; Zhang X; Zhang L; Dai X; Chen H; Xie Q
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):251. PubMed ID: 38589784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis.
    Komaki F; Komaki Y; Micic D; Ido A; Sakuraba A
    J Autoimmun; 2017 Jan; 76():38-52. PubMed ID: 27913060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis.
    Shihab Z; Yeomans ND; De Cruz P
    J Crohns Colitis; 2016 Aug; 10(8):979-88. PubMed ID: 26755733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
    Mozaffari S; Abdolghaffari AH; Nikfar S; Abdollahi M
    Hum Exp Toxicol; 2015 May; 34(5):445-59. PubMed ID: 25378092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TNFα therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis.
    Narula N; Al-Dabbagh R; Dhillon A; Sands BE; Marshall JK
    Inflamm Bowel Dis; 2014 Oct; 20(10):1862-9. PubMed ID: 24983985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis.
    Nielsen OH; Gubatan JM; Juhl CB; Streett SE; Maxwell C
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):74-87.e3. PubMed ID: 32931960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.
    Julsgaard M; Hvas CL; Gearry RB; Gibson PR; Fallingborg J; Sparrow MP; Bibby BM; Connell WR; Brown SJ; Kamm MA; Lawrance IC; Vestergaard T; Svenningsen L; Baekdal M; Kammerlander H; Walsh A; Boysen T; Bampton P; Radford-Smith G; Kjeldsen J; Andrews JM; Subramaniam K; Moore GT; Jensen NM; Connor SJ; Wildt S; Wilson B; Ellard K; Christensen LA; Bell SJ
    Inflamm Bowel Dis; 2020 Jan; 26(1):93-102. PubMed ID: 31141607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.
    Kammerlander H; Nielsen J; Knudsen T; Kjeldsen J; Friedman S; Nørgård BM
    Inflamm Bowel Dis; 2017 Nov; 23(11):1916-1923. PubMed ID: 28858070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestogens for preventing miscarriage: a network meta-analysis.
    Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Leung KK; Tandon P; Govardhanam V; Maxwell C; Huang V
    Inflamm Bowel Dis; 2021 Mar; 27(4):550-562. PubMed ID: 32469057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.
    Meyer A; Neumann A; Drouin J; Weill A; Carbonnel F; Dray-Spira R
    Ann Intern Med; 2022 Oct; 175(10):1374-1382. PubMed ID: 36162111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.
    Nielsen OH; Loftus EV; Jess T
    BMC Med; 2013 Jul; 11():174. PubMed ID: 23902720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of surgical therapies for inflammatory bowel disease on female fertility.
    Lee S; Crowe M; Seow CH; Kotze PG; Kaplan GG; Metcalfe A; Ricciuto A; Benchimol EI; Kuenzig ME
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012711. PubMed ID: 31334846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of Pregnancy Outcomes after Exposure to TNF-α Inhibitors During Pregnancy for the Treatment of Arthritic Diseases.
    Mirdamadi K; Salinas T; Vali R; Papadimitropoulos M; Piquette-Miller M
    J Popul Ther Clin Pharmacol; 2018 Apr; 25(1):e53-e56. PubMed ID: 29949681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis.
    Barenbrug L; Groen MT; Hoentjen F; van Drongelen J; Reek JMPAVD; Joosten I; de Jong EMGJ; van der Molen RG
    J Autoimmun; 2021 Aug; 122():102676. PubMed ID: 34126302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Kammerlander H; Nielsen J; Kjeldsen J; Knudsen T; Friedman S; Nørgård B
    Inflamm Bowel Dis; 2017 Jun; 23(6):1011-1018. PubMed ID: 28346274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden.
    Bröms G; Kieler H; Ekbom A; Gissler M; Hellgren K; Lahesmaa-Korpinen AM; Pedersen L; Schmitt-Egenolf M; Sørensen HT; Granath F
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):316-327. PubMed ID: 32020767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction.
    Siristatidis CS; Sertedaki E; Karageorgiou V; Vaidakis D
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013063. PubMed ID: 32797689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.